Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology
PLOS One · 2025
DOI: 10.1371/journal.pone.0339457 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Jinghan Fan und 13 weiteren Autor:innen. Beteiligte Einrichtung: The Second Affiliated Hospital of Zhejiang Chinese Medical University (Xinhua Hospital of Zhejiang Province), Hangzhou, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, COVID-19 Drug Treatment, Sepsis. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Science and Technology Project of Zhejiang Province, Zhejiang Traditional Chinese Medicine Administration, Medical and Health Research Project of Zhejiang Province.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis and COVID-19 are the two mutually-reinforcing risk factors, whose interaction drastically increases mortality rate. Jinhong decoction (JHD) as a Chinese medicine exhibits clinical efficacy against them, but related action mechanism remains to be explored. To this end, using network pharmacology, this study screened active ingredients of JHD and their targets from TCMSP, HERB, PubChem and SwissTargetPrediction databases as well as the targets for these two diseases from DisGeNET, OMIM, Drugbank, TTD, and GeneCards. By intersecting drug and disease targets, we identified common targets and constructed a drug-ingredient-target network. GO and KEGG enrichment analyses revealed key target-related signaling pathways, and transcriptomics analysis further validated tissue distribution of these targets and their expressions. Our identified six key target genes ( AKT1 , MMP9 , ICAM1 , TLR4 , BCL2 , and HIF1A ) were mainly involved in the regulations of immunometabolism, inflammation, and cell survival in both diseases. Functional enrichment analysis indicated that JHD displayed synergistic efficacy against both diseases by simultaneously modulating HIF-1, TNF, and NF-κB signaling pathways. Tissue distribution analyses of these 6 key target genes revealed that CD33 + myeloid cells, fetal lung cells, and bronchial epithelial cells might play an important role in treating both diseases. Overall, this study demonstrates that JHD treats sepsis and COVID-19 through a multi-ingredient, multi-target, and multi-pathway inter-related mechanism, exhibiting a great application potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- The Second Affiliated Hospital of Zhejiang Chinese Medical University (Xinhua Hospital of Zhejiang Province), Hangzhou, China.
- Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Jinghan Fan, Yuzhou He
Förderung
- Medical Science and Technology Project of Zhejiang Province
- Zhejiang Traditional Chinese Medicine Administration
- Medical and Health Research Project of Zhejiang Province
- the Research Project of Zhejiang Chinese Medical University
Zitieren
APA
Fan, J., Yang, Y., Zhang, F., Wu, X., Li, J., Liang, L., Tang, Q., Yan, B., Zhang, J., Pan, X., Jin, G., Wei, C., Han, P., & He, Y. (2025). Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology. PLOS One. https://doi.org/10.1371/journal.pone.0339457
Vancouver
Fan J, Yang Y, Zhang F, Wu X, Li J, Liang L, et al. Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology. PLOS One. 2025. doi:10.1371/journal.pone.0339457
BibTeX
@article{Fan2025,
author = {Fan, Jinghan and Yang, Yang and Zhang, Fan and Wu, Xiaowei and Li, Jiajun and Liang, Li and Tang, Qi and Yan, Bo and Zhang, Jiancheng and Pan, Xuming and Jin, Guangjun and Wei, Changlong and Han, Pingping and He, Yuzhou},
title = {Analysis of molecular mechanism of Chinese medicine Jinhong decoction (JHD) in synergistically treating sepsis and COVID-19 based on network pharmacology},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339457}
}
EUVIMED